Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Sclerostin-targeted delivery of PCSK9 siRNA reverses osteoporosis in OVX mice | Synapse
March 3, 2026
Sclerostin-targeted delivery of PCSK9 siRNA reverses osteoporosis in OVX mice
HW
Hongling Wu
LH
Liyuan Huang
FS
Fangfang Song
Ver todo
Puntos clave
Reversal of osteoporosis observed following targeted delivery of PCSK9 siRNA.
Ovariectomized (OVX) mice showed significant improvements in bone density metrics.
Targeted delivery approach enhances siRNA efficacy in disrupting sclerostin pathways.
This research highlights the potential of targeting specific molecular pathways for therapeutic interventions.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Wu et al. (Tue,) studied this question.
synapsesocial.com/papers/69a75b73c6e9836116a22c9f
https://doi.org/https://doi.org/10.1016/j.bone.2026.117808
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir